Literature DB >> 508688

Prognosis for rubeosis iridis following central retinal vein occlusion.

S H Sinclair, E S Gragoudas.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 508688      PMCID： PMC1043609          DOI： 10.1136/bjo.63.11.735

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  11 in total

1.  Neovascularization in ocular disease.

Authors:  R SMITH
Journal:  Trans Ophthalmol Soc U K       Date:  1961

2.  Glaucoma due to thrombosis of the central vein of the retina.

Authors:  S VANNAS
Journal:  Ophthalmologica       Date:  1961       Impact factor: 3.250

3.  Neovascularization in ocular disease.

Authors:  N ASHTON
Journal:  Trans Ophthalmol Soc U K       Date:  1961

4.  New vessel formation in retinal branch vein occlusion.

Authors:  J S Shilling; E M Kohner
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

5.  Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma.

Authors:  L Laatikainen
Journal:  Br J Ophthalmol       Date:  1977-04       Impact factor: 4.638

6.  Behaviour of the iris vasculature in central retinal vein occlusion: a fluorescein angiographic study of the vascular response of the retina and the iris.

Authors:  L Laatikainen; R K Blach
Journal:  Br J Ophthalmol       Date:  1977-04       Impact factor: 4.638

Review 7.  Photocoagulation in retinal vein occlusion.

Authors:  S C Sedney
Journal:  Doc Ophthalmol       Date:  1976-01-28       Impact factor: 2.379

8.  A prospective study of xenon arc photocoagulation for central retinal vein occlusion.

Authors:  D R May; M L Klein; G A Peyman
Journal:  Br J Ophthalmol       Date:  1976-12       Impact factor: 4.638

9.  Fluorescein angiography and its prognostic significance in central retinal vein occlusion.

Authors:  L Laatikainen; E M Kohner
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

10.  Photocoagulation in retinal venous occlusion.

Authors:  L Laatikainen
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-06
View more
  16 in total

1.  Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.

Authors:  C Hvarfner; A Hillarp; J Larsson
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Secondary glaucomas: the tasks ahead.

Authors:  R Krishnadas; R Ramakrishnan
Journal:  Community Eye Health       Date:  2001

Review 3.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

4.  A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.

Authors:  L L Hansen; J Wiek; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

5.  Score Study Report 12: Development of venous collaterals in the Score Study.

Authors:  David V Weinberg; Aimee E Wahle; Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Barbara A Blodi
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

6.  Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year.

Authors:  S Arséne; B Giraudeau; M-L Le Lez; P J Pisella; L Pourcelot; F Tranquart
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

7.  Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.

Authors:  M J Elman
Journal:  Trans Am Ophthalmol Soc       Date:  1996

8.  [Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions].

Authors:  A Mirshahi; K Lorenz; C Kramann; B Stoffelns; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

9.  A prospective follow-up study of panretinal photocoagulation in preventing neovascular glaucoma following ischaemic central retinal vein occlusion.

Authors:  L Laatikainen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

10.  Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

Authors:  S Wolf; O Arend; B Bertram; A Remky; K Schulte; K J Wald; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.